EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Persistent Immunity From Historic Smallpox Vaccination and Its Limited Cross-Neutralization of Monkeypox Virus: A Population-based Serological Study in Taiwan

An-Yu Chen iD, Yen-Chen Chen iD, Wen-Hui Fang iD, Le-Tien Lin iD, Yi-Jen Hung, Chih-Heng Huang iD

Open Forum Infectious Diseases · 02.02.2026 · 13 (2)

DOI: 10.1093/ofid/ofag018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 14.01.2026. Verfasst von An-Yu Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Preventive Medicine, National Defense Medical University, Taipei, Taiwan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Taiwan, Ministry of National Defense Medical Affairs Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding the extent of cross-protection conferred by the historic smallpox vaccination and the immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) after the 2022 global mpox outbreak is essential to inform current prevention strategies. In this study, we assessed the seropositivity and neutralizing capacities of the vaccinia virus (VACV)- and monkeypox virus (MPXV)-specific antibodies in 260 Taiwanese individuals.

Methods

We analyzed serum samples from 260 individuals in Taiwan, stratified by their birth year, before or after 1979, the year of smallpox vaccination cessation. ELISA and plaque reduction neutralization tests were conducted to assess VACV- and MPXV-specific antibody responses. Furthermore, we evaluated an additional cohort of MVA-BN vaccines (n = 9) before and after vaccination.

Results

Over 80% of individuals born before 1979 retained VACV-reactive antibodies, with 84% of this seropositive subgroup exhibiting neutralizing activity. We detected cross-reactive MPXV antibodies in 69% of individuals who were VACV-seropositive; however, only 65% had MPXV-neutralizing capacity, with titers significantly lower than those against VACV. MVA-BN vaccination enhanced VACV and MPXV antibody levels; however, MPXV-neutralizing titers remained low, particularly in individuals without prior smallpox immunization.

Conclusions

Historical smallpox vaccination induces long-lasting humoral immunity, and a correlation between VACV and MPXV antibody levels further suggests that it provides some degree of cross-protection against MPXV infection. MVA-BN boosted orthopoxvirus immunity; however, it may be limited in MPXV neutralization in vaccine-naïve populations. These findings offer useful insights for future mpox vaccination strategies and public health planning in regions with varying smallpox vaccination histories.

Schlagwörter

Stichwörter der Autor:innen

MPXVMVA-BNhistoric smallpox vaccination

Autor:innen und Institutionen

  • Institute of Preventive Medicine, National Defense Medical University, Taipei, Taiwan.
  • Graduate Institute of Medical Sciences, National Defense Medical University, Taipei, Taiwan.
  • Division of Family Medicine, Department of Family and Community Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Department of Ophthalmology, Tri-Service General Hospital Songshan Branch, National Defense Medical University, Taipei, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.

ORCID-Profile: An-Yu Chen, Yen-Chen Chen, Wen-Hui Fang, Le-Tien Lin, Chih-Heng Huang

Förderung

  • National Science and Technology Council, Taiwan
  • Ministry of National Defense Medical Affairs Bureau

Zitieren

APA

Chen, A. Y., Chen, Y. C., Fang, W. H., Lin, L. T., Hung, Y. J., & Huang, C. H. (2026). Persistent Immunity From Historic Smallpox Vaccination and Its Limited Cross-Neutralization of Monkeypox Virus: A Population-based Serological Study in Taiwan. Open Forum Infectious Diseases, 13(2). https://doi.org/10.1093/ofid/ofag018

Vancouver

Chen AY, Chen YC, Fang WH, Lin LT, Hung YJ, Huang CH. Persistent Immunity From Historic Smallpox Vaccination and Its Limited Cross-Neutralization of Monkeypox Virus: A Population-based Serological Study in Taiwan. Open Forum Infectious Diseases. 2026;13(2). doi:10.1093/ofid/ofag018

BibTeX
@article{Chen2026,
  author = {Chen, An-Yu and Chen, Yen-Chen and Fang, Wen-Hui and Lin, Le-Tien and Hung, Yi-Jen and Huang, Chih-Heng},
  title = {Persistent Immunity From Historic Smallpox Vaccination and Its Limited Cross-Neutralization of Monkeypox Virus: A Population-based Serological Study in Taiwan},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {2},
  doi = {10.1093/ofid/ofag018}
}
Kostenlos starten →